Skip to main content

Antonio Román Broto

I am a pulmonologist specialising in lung diseases in advanced stages and in lung transplants. I also specialise in pulmonary vascular disease and cystic lung diseases. Previously I was the medical coordinator for the Lung Transplant Programme for Adults. I am currently the Director of Healthcare at Vall d'Hebron University Hospital.

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca
Director of Healthcare
Healthcare Management
Children's Hospital and Woman's Hospital
Director of Healthcare
Healthcare Management
Traumatology, Rehabilitation and Burns Hospital
Director of Healthcare
Healthcare Management
Cross-departmental services

Antonio Román Broto

Institutions of which they are part

Main researcher
Pneumology
Vall Hebron Institut de Recerca
Director of Healthcare
Healthcare Management
Children's Hospital and Woman's Hospital
Director of Healthcare
Healthcare Management
Traumatology, Rehabilitation and Burns Hospital
Director of Healthcare
Healthcare Management
Cross-departmental services

I am a pulmonologist specialising in lung diseases in advanced stages and in lung transplants. I also specialise in pulmonary vascular disease and cystic lung diseases. Previously I was the medical coordinator for the Lung Transplant Programme for Adults. I am currently the Director of Healthcare at Vall d'Hebron University Hospital.

I studied medicine at the UAB before becoming a doctor at the Vall d'Hebron Hospital. I then took part in a training residency in pulmonology, also at our hospital. From that point I started to develop the Lung Transplant Programme at the Vall d’Hebron with the guidance and support of Dr Ferran Morell. The Lung Transplant Programme at the Vall d’Hebron was the first to be developed in Spain and is currently a centre of reference in the country. The programme helps 10 million people and is well-known at an international level. Until now I was the medical coordinator for the programme. We have also carried out very important activity in the field of pulmonary vascular disease and cystic lung diseases. Vall d’Hebron is recognised by CatSalut as one of two expert centres in pulmonary hypertension. We are also an international LAM Clinic, recognised by the LAM Foundation in the USA. My teaching experience includes pre-degree training as an associate professor of medicine. I have developed multiple postgraduate training activities, with courses in transplantation and also pulmonary diseases at an advanced stage and pulmonary vascular disease. Finally, my research activity has focused on this field, with numerous publications in the most prestigious journals in this speciality, obtaining competitive funding and directing a small research group at the Vall d’Hebron Research Institute (VHIR).

Research lines

Lung transplantation and pulmonary hypertension.

The Group performed the first successful lung transplantation in Spain. Currently, it is one of the hospitals where the largest number of lung transplants are carried out annually, which places it among the leading centers in Europe and the world for this activity.

IP: Antonio Román Broto

Projects

ADN CIRCULANTE COMO BIOMARCADOR NO INVASIVO TRAS UN TRASPLANTE DE PULMÓN

IP: Antonio Román Broto
Collaborators: Juliana Esperalba Esquerra, Carles Bravo Masgoret, Vanessa Casares Rodríguez, Judith Sacanell Lacasa, Cristina Berastegui Garcia, Manuel López Meseguer, Berta Saez Gimenez, Maria Martinez Martinez, Jordi Riera del Brío, Marina García García de Acilu
Funding agency: Instituto de Salud Carlos III
Funding: 159720
Reference: PI17/01485
Duration: 01/01/2018 - 30/06/2022

Grup de Recerca de Pneumologia

IP: Jaume Ferrer Sancho
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz, Eva Polverino
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding: 20000
Reference: 2017SGR0434
Duration: 01/01/2017 - 30/09/2021

Enfermedad tromboembólica tras el trasplante pulmonar

IP: Antonio Román Broto
Collaborators: Berta Saez Gimenez
Funding agency: Fundació Institut de Recerca HUVH
Funding: 46800
Reference: PRED-VHIR-2015-28
Duration: 01/03/2016 - 28/02/2019

Pneumologia (GRC)

IP: Ferran Morell Brotad
Collaborators: Esther Rodríguez González, Sergi Martí Beltran, Mª Jose Jurado Luque, Marc Miravitlles Fernández, Ana Villar Gomez, Antonio Román Broto, Antonio Álvarez Fernandez, Victor Monforte Torres, Patricia Lloberes Canadell, Javier de Gracia Roldán, Odile Romero Santo-Tomas, Sonia Lopez Rodriguez, Montserrat Murillo Andres, Miriam Barrecheguren Fernández, Carles Bravo Masgoret, Mario Culebras Amigo, Fco. Javier Muñoz Gall, Marta Castro D la Visitación, Gabriel Sampol Rubio, Jaume Ferrer Sancho, Maria Antonia Ramon Belmonte, Rosa Lloria Verges, Oriol Roca Gas, Mercedes Pallero Castillo, Mª Jesús Cruz Carmona, Cristina Berastegui Garcia, Manuel López Meseguer, Susana Gómez Olles, Berta Saez Gimenez, Iñigo Ojanguren Arranz
Funding agency: Agència Gestió Ajuts Universitaris i de Recerca
Funding:
Reference: 2014 SGR 523
Duration: 01/01/2014 - 31/12/2016

Related news

Vall d'Hebron participated in the study in which more than half of the patients who received treatment with bacteriophages experienced significant improvements

La recerca és fonamental per contrarestar els efectes de la pol·lució, que segons l’AEMPS, va ser la causa de més de 300.000 morts prematures a la UE el 2020.

Pulmonary hypertension is a risk factor for patients who need surgery and, therefore, defining strategies for its management is important to allow a favorable clinical evolution.

Related professionals

Janna Anthonina Slabbekoorn

Janna Anthonina Slabbekoorn

Tècnic/a Grau Superior
International Projects Unit
Competitive Projects Area
Read more
Maria Francesca Cortese

Maria Francesca Cortese

Main researcher
Microbiology
Read more
Efráin Santiago Cordero Vázquez

Efráin Santiago Cordero Vázquez

Predoctoral researcher
Diabetes and Metabolism
Read more
Matteo Pusceddu

Matteo Pusceddu

Postdoctoral researcher
Physiology and Pathophysiology of the Digestive Tract
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.